Pharmacology Final Exam? Cut down your study time and approach exam day
with absolute confidence using this comprehensive Chamberlain Practice EXAM |
Questions & Verified Answers study package.
This guide is meticulously designed to mirror the core concepts, high-yield topics,
and critical thinking required to ace the Chamberlain NR 565 Advanced
Pharmacology Final.
What’s Included inside:
• Comprehensive Practice Questions: Hand-picked questions covering
essential advanced pharmacology principles, specific drug classes,
prescriptive authority, and clinical applications.
• Verified, Detailed Answers: No more guessing games. Every question
features a verified correct answer to help you lock in the right concepts
immediately.
• Rationales & Key Concepts: Understand the why behind the correct choice,
helping you master tricky drug interactions, adverse effects, and first-line
treatments.
Key Topics Covered:
• Advanced Pharmacokinetics & Pharmacodynamics
• Prescribing for Chronic & Acute Conditions (Hypertension, Diabetes, Asthma,
etc.)
• Antibiotics, Antivirals, and Antifungals
• Geriatric, Pediatric, and Obstetric Prescribing Considerations
• Controlled Substance Regulations & Safe Prescribing Practices
Why Choose This Study Guide?
• Save Time: Skip the endless textbook scrolling and focus directly on high-
yield, exam-relevant content.
• Boost Confidence: Test your knowledge before the actual exam to identify
and fix your weak areas.
• Study Anywhere: Fully digital, searchable, and easy to review on your
laptop, tablet, or phone.
1
, Disclaimer: This document is a study aid and practice exam designed for review
purposes to help students understand course concepts. It is not the actual official
university exam.
In which patient population is Metformin contraindicated in?
A. Diabetics with HA1c < 7.0%
B. Patients older than 50
C. Alcoholics
D. Women suffering from infertility - Answer✅ C. Alcoholics
What lab value suggests metformin might be contraindicated?
A. eGFR <30
B. Crea 0.8
C. WBC 7.8
D. Bun 17 - Answer✅ A. eGFR <30
What medication is contraindicated to treat diabetes if a patient already has a
cardiac ejection fraction rate of 40%?
A. Second Generation sulfonyureas
B. Thiazolidinediones
C. Dopamine Agonist
D. Glucosidase Inhibitor - Answer✅ B. Thiazolidinediones
Sabrina is a 35-year-old female who presents with complaints of fatigue, anxiety, and
palpitations. She has a long history of obesity and reports that she is happy that she
has lost 23 pounds in the last 2 months. She also reports that she has trouble
sleeping and her husband complains that she is keeping the house too cold.
Physical exam reveals slight tachycardia at 104 bpm and a slightly enlarged thyroid.
Thyroid testing reveals hyperthyroidism or Grave's disease.
Which of the following agents is the first-line treatment for hyperthyroidism or Grave's
disease?
A. Methimazole
B. Metoprolol
C. Allopurinol
D. Levothyroxine - Answer✅ A. Methimazole
Which of the following medications would be considered the first line of treatment for
a newly diagnosed Diabetic patient with adequate renal and hepatic function?
2
, A: NovoLog Sliding Scale Insulin
B: Liraglutide (Victoza)
C: Oral Metformin
D: Glipizide - Answer✅ C: Oral Metformin
Of the following medications, which is most likely to cause hypoglycemia?
A. Metformin
B. Insulin
C. Incretin mimetics
D. Thiazolidinediones - Answer✅ B. Insulin
Which symptoms are most expected of a patient diagnosed with hypothyroidism?
A. shortness of breath, wheezing, fatigue
B. tachycardia, insomnia, weight loss, goiter
C. irritability, anxiety, dizziness, increased sweating
D. dry pale skin, brittle hair, fatigue, myxedema - Answer✅ D. dry skin, brittle hair,
fatigue, myxedema
Patients with an increased risk for UTIs and genital infections or an active diagnosis,
should avoid what drug class/es for treatment of Type II Diabetes?
A. Thiazolidinediones (Glitazones)
B. Biguanide.
C. Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors.
D. All of the above. - Answer✅ C. Sodium-Glucose Cotransporter 2 (SGLT-2)
Inhibitors.
A 45-year-old patient with a history of type 2 diabetes presents to the clinic for a
follow-up appointment. The healthcare provider has prescribed metformin as part of
the treatment plan. Which of the following statements regarding metformin is
correct?
A. Metformin primarily stimulates insulin production from the pancreas.
B. Metformin reduces glucose levels primarily by decreasing insulin resistance.
C. Metformin is associated with a risk of hypoglycemia.
D. Metformin improves insulin sensitivity and reduces hepatic glucose production. -
Answer✅ D. Metformin improves insulin sensitivity and reduces hepatic glucose
production.
In what part of the body are SGLT-2 (sodium-glucose cotransporter 2) inhibitors
active?
A. Small intestine
B. Pancreas
C. Renal tubules
D. Stomach - Answer✅ C. Renal tubules
3